Literature DB >> 10707108

A 2-year prospective study in China provides epidemiological evidence for resistance in humans to re-infection with Schistosoma japonicum.

Y S Li1, A C Sleigh, A G Ross, Y Li, G M Williams, S J Forsyth, M Tanner, D P McManus.   

Abstract

In 1996, 250 people living in the Dongting-Lake region of China were selected for a 2-year study. All had been or were infected with Schistosoma japonicum. All were treated with praziquantel, although eggs of S. japonicum were only detected in stool samples from 75 of the subjects. In 1998, 213 (85.5%) of these subjects, then with a mean (S.D.) age of 40.2 (14.2) years, provided stool samples for final assessment. Forty-nine (23%) of the 213 were found to be re-infected in 1998, with a geometric mean intensity of infection among the infected of 64.5 eggs/g faeces. The rate of re-infection was highest among those aged < 10 years, declining with increasing age, and higher in males than females (27.3% v. 8.3%; P < 0.005). The mean intensity of infection among the infected males was also higher than that among the infected females [72.4 (4.8) v. 17.8 (2.5) eggs/g; P < 0.005]. Water contact by the subjects was estimated from activity diaries, for 141 days over the 2-year study period, and expressed as skin exposure, in m2-min/day. The mean exposure of a group of subjects was calculated by detransforming the mean of the fourth-root-transformed (i.e. normalized) values for the exposures of each subject within the group. Overall, the 213 individuals had a mean exposure of 6.2 m2-min/day. Differences in occupation led to males having much higher mean water exposures than females (9.2 v. 1.1 m2-min/day). As there was an inverse association between age-specific exposure and age-specific re-infection intensity, the marked reduction seen in intensity of re-infection with increasing age is not attributable to decreasing exposure to water. Instead, the results of this 2-year cohort study provide evidence for age-dependent resistance to re-infection with S. japonicum. The 213 subjects who were followed up were classified, according to epidemiological outcome at the end of the study and the data on water contact, as 'susceptible' (N = 49; 23%), 'insusceptible' (N = 29; 13.6%) or of 'uncertain status' (N = 135; 63.4%). Thus, 78 subjects who are potentially informative in terms of immunogenetics were identified. Further investigation of these individuals should help to shed some light on the role of immunogenetic status in human immunity to Schistosoma japonicum.

Entities:  

Mesh:

Year:  1999        PMID: 10707108     DOI: 10.1080/00034989958131

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  14 in total

1.  Familial aggregation of human infection with Schistosoma japonicum in the Poyang Lake region, China.

Authors:  Magda K Ellis; Yuesheng Li; Zhu Rong; Honggen Chen; Donald P McManus
Journal:  Int J Parasitol       Date:  2005-10-13       Impact factor: 3.981

Review 2.  Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam.

Authors:  Donald P McManus; Darren J Gray; Yuesheng Li; Zheng Feng; Gail M Williams; Donald Stewart; Jose Rey-Ladino; Allen G Ross
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 3.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  A cluster-randomized bovine intervention trial against Schistosoma japonicum in the People's Republic of China: design and baseline results.

Authors:  Darren J Gray; Gail M Williams; Yuesheng Li; Honggen Chen; Robert S Li; Simon J Forsyth; Adrian G Barnett; Jiagang Guo; Zheng Feng; Donald P McManus
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

5.  Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity.

Authors:  Agnès Fleury; Alain Dessein; Pierre Marie Preux; Michel Dumas; Graciela Tapia; Carlos Larralde; Edda Sciutto
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

6.  A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China.

Authors:  Xun-Ya Hou; Donald P McManus; Darren J Gray; Julie Balen; Xin-Song Luo; Yong-Kang He; Magda Ellis; Gail M Williams; Yue-Sheng Li
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

7.  Five-year longitudinal assessment of the downstream impact on schistosomiasis transmission following closure of the Three Gorges Dam.

Authors:  Darren J Gray; Aaron P Thrift; Gail M Williams; Feng Zheng; Yue-Sheng Li; Jiagang Guo; Honggen Chen; Tianping Wang; Xin Jiang Xu; Rong Zhu; Hongqing Zhu; Chun Li Cao; Dan Dan Lin; Zhen Yuan Zhao; Robert S Li; George M Davis; Donald P McManus
Journal:  PLoS Negl Trop Dis       Date:  2012-04-10

8.  Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE.

Authors:  Angela Pinot de Moira; Anthony J C Fulford; Narcis B Kabatereine; John H Ouma; Mark Booth; David W Dunne
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

9.  A 5-year longitudinal study of schistosomiasis transmission in Shian village, the Anning River Valley, Sichuan Province, the Peoples' Republic of China.

Authors:  Rong Zhu; Darren J Gray; Aaron P Thrift; Gail M Williams; Yi Zhang; Dong-Chuan Qiu; Feng Zheng; Yue-Sheng Li; Jiagang Guo; Hong-Qing Zhu; Wei-Ping Wu; Robert S Li; Donald P McManus
Journal:  Parasit Vectors       Date:  2011-03-24       Impact factor: 3.876

10.  Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis?

Authors:  Elizabeth J Carlton; Alan Hubbard; Shuo Wang; Robert C Spear
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.